Articles
Media
Publications
Conferences
CME/CE
Resources
Subscribe

Spotlight -

ZEISS Clinical Cases|

Heidelberg Engineering: Enhancing the Patient Journey

Loredana Smarandache, MD

Articles by Loredana Smarandache, MD

FLORetina 2025: Real-world aflibercept data supports clinically guided, flexible nAMD dosing

ByLoredana Smarandache, MD,Kassi Filkins,Martin David Harp

December 13th 2025

Research reveals how COVID-19 disrupted anti-VEGF treatment schedules, yet flexible regimens maintain visual outcomes for neovascular AMD patients.

Latest Updated Articles

FLORetina 2025: Real-world aflibercept data supports clinically guided, flexible nAMD dosing
Published: December 13th 2025 | Updated:

Trending on Ophthalmology Times Europe

FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen

Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis

FLORetina 2025: A second Müller glial cell type in the human fovea